ConductScience.org, home

Gene · 6607

Papers3,510

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1,381 to 1,400 of 3,510

Download this page as JSON
TitleJournalYearPMIDFound bySource
New approaches to target RNA binding proteins.Curr Opin Chem Biol202133535093PubTator, text miningPubMed
Hinokiflavone and Related C-O-C-Type Biflavonoids as Anti-cancer Compounds: Properties and Mechanism of Action.Nat Prod Bioprospect202133534099PubTator, text miningPubMed
Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance.Appl Clin Genet202133531827PubTator, text miningPubMed
Intellectual abilities, language comprehension, speech, and motor function in children with spinal muscular atrophy type 1.J Neurodev Disord202133530934PubTator, text miningPubMed
Gene-based therapies for neurodegenerative diseases.Nat Neurosci202133526943PubTator, text miningPubMed
RBM10: Structure, functions, and associated diseases.Gene202133515724PubTator, text miningPubMed
Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA.Sci Transl Med202133504650PubTator, text miningPubMed
Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE study.Muscle Nerve202133501671PubTator, text miningPubMed
The Relationship between Body Composition, Fatty Acid Metabolism and Diet in Spinal Muscular Atrophy.Brain Sci202133498293PubTator, text miningPubMed
Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis.Mol Divers202133492566PubTator, text miningPubMed
Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments.Orphanet J Rare Dis202133485382PubTator, text miningPubMed
Comprehensive Mutation Analysis and Report of 12 Novel Mutations in a Cohort of Patients with Spinal Muscular Atrophy in Iran.J Mol Neurosci202133481221PubTator, text miningPubMed
Quantification of disease progression in spinal muscular atrophy with muscle MRI-a pilot study.NMR Biomed202133480130PubTator, text miningPubMed
Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment.Orphanet J Rare Dis202133472673PubTator, text miningPubMed
Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals.
Nucleic Acid Ther202133470890PubTator, text miningPubMed
Structure of SRSF1 RRM1 bound to RNA reveals an unexpected bimodal mode of interaction and explains its involvement in SMN1 exon7 splicing.Nat Commun202133462199PubTator, text miningPubMed
Infantile spinal muscular atrophy - the potential for cure of a fatal disease.J Neonatal Perinatal Med202133459670PubTator, text miningPubMed
Targeting RNA with small molecules: from fundamental principles towards the clinic.Chem Soc Rev202133458725PubTator, text miningPubMed
Spinal Muscular Atrophy Type 3 Showing a Specific Pattern of Selective Vulnerability on Muscle Ultrasound.Intern Med202133456041PubTator, text miningPubMed
Effects of Survival Motor Neuron Protein on Germ Cell Development in Mouse and Human.Int J Mol Sci202133440839PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6607/papers?page=70